Occurrence and Characteristics of Class 1 and 2 Integrons in Pseudomonas aeruginosa Isolates from Patients in Southern China by Zhenbo Xu et al.
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2009, p. 230–234 Vol. 47, No. 1
0095-1137/09/$08.000 doi:10.1128/JCM.02027-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Occurrence and Characteristics of Class 1 and 2 Integrons in
Pseudomonas aeruginosa Isolates from Patients in
Southern China
Zhenbo Xu,1,2 Lin Li,1 Mark E. Shirtliff,2 M. J. Alam,3
Shinji Yamasaki,1,4 and Lei Shi1,4*
College of Light Industry and Food Sciences, South China University of Technology, Guangzhou, China1; Department of
Microbial Pathogenesis, Dental School, University of Maryland—Baltimore, 7th Floor South, 650 W. Baltimore Street, Baltimore,
Maryland 212012; College of Agriculture & Life Sciences, Texas A & M University, College Station,
Texas 778433; and Graduate School of Life and Environmental Sciences,
Osaka Prefecture University, Osaka, Japan4
Received 19 October 2008/Accepted 10 November 2008
Class 1 and 2 integrons were detected in 45.8% (54/118) and 19.5% (23/118) of our tested Pseudomonas
aeruginosa isolates, respectively. Three strains were positive for both the integrons. This is the first report
of class 2 integrons in P. aeruginosa and also of isolates carrying class 1 and 2 integrons simultaneously.
Pseudomonas aeruginosa remains one of the most impor-
tant pathogens in the nosocomial setting (14), and it not
only is naturally resistant to many antimicrobial agents but
also has the distinctive capacity via multiple mechanisms to
become resistant to virtually all the antibiotics available
commercially (9, 38). A genetic element, the integron, is
potentially a major agent in the dissemination of multidrug
resistance among gram-negative bacteria, especially in
Pseudomonas (16). Gene cassettes, present in the variable
region of integrons, are discrete mobile units comprising a
gene, usually an antibiotic resistance gene, and a recombi-
nation site that is recognized by an integrase. The class 1
integron has been identified as a primary source of resis-
tance genes within gram-negative and -positive bacteria (6,
20, 33, 36, 40, 41, 42), and the class 2 integron has been seen
in Acinetobacter sp. isolates throughout the world (28).
However, class 2 integrons in P. aeruginosa strains had not
yet been investigated. In this study, 118 imipenem-resistant
P. aeruginosa isolates were chosen for the investigation of
class 1 and 2 integrons because of the relatively high inte-
gron-positive rate in imipenem-resistant isolates.
From 2001 to 2005, a total of 118 consecutive nonduplicated
P. aeruginosa isolates which were intermediate or resistant
(nonsusceptible) to imipenem (IMP; MIC  8 g/ml) were
isolated from the First Affiliated Hospital of Jinan University,
an 850-bed tertiary-level teaching hospital in Guangzhou,
China. Identification of isolates to the species level and anti-
microbial susceptibility testing were performed with the Vitek
system (bioMerieux Vitek Systems Inc., Hazelwood, MO). The
quality control strain used was P. aeruginosa ATCC 27853.
Template DNA used for PCR was prepared as described pre-
viously (16). Detection and characterization of class 1 and 2
integrons were performed as described previously (35, 41).
PCR products of the variable region were further character-
ized by restriction fragment length polymorphism (RFLP), and
at least two different restriction endonucleases were chosen for
each RFLP assay, and the DNA sequence for at least one of
the variable region amplification products belonging to each of
the individual RFLP patterns was determined as described
previously (35). Seventy-four integron-positive P. aeruginosa
isolates were subjected to genotyping analysis by randomly
amplified polymorphic DNA PCR (RAPD-PCR) as described
previously (35).
The multidrug resistance (defined as resistance to six or
more antibiotics) rates of integron-positive and -negative
strains were 93.2% and 18.2%, respectively (Table 1). Class
1 integron was detected in 54 isolates, and 51 strains carried
the 3 conserved region of qacE1-sul1. Seven different sizes
of variable region were found, with fragments with lengths
ranging between 879 bp and 2,655 bp (Table 2). The array of
the aacA4-catB3-dfrA1 noncoding gene cassette has been
reported previously (16). The defective class 1 integron with
a sul3 gene, which was identical with that seen in Salmonella
enterica serovar Typhimurium (AY047357), had never been
reported to be seen in isolates of P. aeruginosa. Class 2
integrons were found in 23 P. aeruginosa isolates, and all
strains harbored the same array of three cassettes, dfrA1-
sat1-aadA1, which was identical to that found in Tn7. Three
strains had both class 1 and 2 integrase genes. No class 3
integrase gene was detected in any of the isolates examined.
RAPD-PCR analysis divided 74 integron-positive P. aerugi-
nosa strains into eight different groups with different RAPD
patterns (genotypes A to H) (Fig. 1). Fifty-one class 1 inte-
gron-positive strains and 3 class 1 and 2 integron-positive
strains were of types A, B, C, F, G, and H, and 20 class 2
integron-positive strains were of types D and E (Table 2).
Integrons have been identified as a primary source of
resistance genes and were suspected to serve as reservoirs of
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FIG. 1. RAPD-PCR patterns of 74 integron-positive Pseudomonas aeruginosa isolates.
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antimicrobial resistance genes within microbial populations
(34), and integron-mediated resistance to antibiotics in clin-
ical isolates of P. aeruginosa has been reported (11, 16, 18,
24, 26). However, all of these studies were concerned with
class 1 integrons, with no exception. Class 2 integrons were
most frequently associated with members of the family
Enterobacteriaceae, such as Escherichia coli and Salmonella
enterica, and also are commonly found in Acinetobacter bau-
mannii and Burkholderia cepacia (1, 3, 4, 19, 25, 27, 37).
However, class 2 integrons in P. aeruginosa had never been
reported. In this study, we detected 51 class 1 integron-
positive strains, 20 class 2 integron-positive strains, and 3
class 1 and 2 integron-positive strains from total of 118
strains. This is the first report, to our knowledge, of class 2
integrons with dfrA1-sat1-aadA1 in P. aeruginosa. Further-
more, it is also the first time clinical P. aeruginosa isolates
carrying class 1 and 2 integrons simultaneously have been
identified.
Class 1 integrons were commonly found in the tested P.
aeruginosa isolates (45.8%, 54/118), but the class 1 integron-
positive rates had been decreasing during the 5-year study
period, with rates of 66.6% (10/15) in 2001, 60.0% (12/20) in
2002, 52.0% (13/25) in 2003, 40.0% (14/35) in 2004, and
21.7% (5/23) in 2005. Class 2 integron appeared in 2003,
with the class 2 integron-positive rates rising for the next
three years, with rates of 8.0% (2/25) in 2003, 20.0% (7/35)
in 2004, and 60.8% (14/23) in 2005, indicating that class 2
integron had been prevalent in recent years. The rate of
integron-positive isolates had changed in a small scale, with
rates of 66.6% in 2001, 60% in 2002 to 2004, and 69.5% in
2005, while the proportion of class 1 integrons had de-
creased more than 45% and the occurrence of class 2 inte-
gron began in 2003. The class 2 integron-positive rate in-
creased to 60% in 2005, suggesting that class 2 integrons
were increasing and suggesting and the possibility of this
class replacing class 1 integron in recent years. The evolu-
tionary success of an integron was determined by two im-
portant factors: the resistance cassettes it carries and the
host range of the plasmid on which it occurs (13). The two
most frequently detected resistance genes in 74 integron-
positive isolates were of the aadA and dfrA families, with
rates of 79.7% (59/74) and 64.9% (48/74), respectively.
Since the two cassettes, dfrA1 and aadA1, have been ob-
served in all class 2 integron-positive isolates, it is reason-
able to presume the transferring of cassettes among differ-
ent integrons (13). So whether class 2 integrons have more
fitness and better survival ability than class 1 integrons un-
der selective pressure and whether some cassettes appear to
have been transferred among integron classes require fur-
ther investigation.
In conclusion, this study showed the occurrence and char-
acteristics of class 1 and 2 integrons in clinical P. aeruginosa.
Nevertheless, further studies need to be conducted to in-
vestigate the cause of the appearance and prevalence of
class 2 integrons in P. aeruginosa in recent years. The find-
ings will help to develop control strategies for infections in
hospitals.
Nucleotide sequence accession number. The nucleotide se-
quence accession number of the defective class 1 integron with
sul3 gene in GenBank is AB281182.
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TABLE 2. Phenotypic and genotypic characteristics of 74 integron-positive Pseudomonas aeruginosa isolates
Strain Yr ofisolation Source
Age (yr),
sexa
Genetic material in isolate withb:
RAPD
pattern Resistance profile
cClass 1 integrons Class 2 integrons
intI1 3 conservedsequence Gene cassette intI2 Gene cassette
010459 2001 Blood 67, M   dfrA12-orfF-aadA2   A ACiGLTToTs
010820 2001 Sputum 79, F   aacA4-cmlA1   B AzCaCeCiGLPTTcToTs
010953 2001 Blood 80, M   dfrA17-aadA5   A ACiGLTToTs
010990 2001 Sputum 80, M   aacA4-cmlA1   B AzCaCeCiGLPTTcToTs
011046 2001 Sputum 51, M   dfrA12-orfF-aadA2   A ACiGLTToTs
011085 2001 Sputum 73, F   dfrA12-orfF-aadA2   A ACiGLTToTs
011087 2001 Sputum 45, F   dfrA12-orfF-aadA2   A ACiGLTToTs
011091 2001 Blood 45, M   dfrA12-orfF-aadA2   A ACiGLTToTs
011095 2001 Sputum 54, M   dfrA12-orfF-aadA2   A ACiGLTToTs
011112 2001 Stool 65, F   dfrA17-aadA5   A ACiGLTToTs
021130 2002 Stool 54, M   aacA4-cmlA1   B AzCaCeCiGLPTTcToTs
021177 2002 Sputum 30, M   aacA4-cmlA1   B AzCaCeCiGLPTTcToTs
021292 2002 Blood 72, F   aacA4-cmlA1   B AzCaCeCiGLPTTcToTs
021328 2002 Sputum 81, F   aacA4-cmlA1   C ACeGPToTs
021336 2002 Sputum 69, M   aacA4-cmlA1   C ACeGPToTs
021352 2002 Sputum 69, F   aacA4-cmlA1   B AzCaCeCiGLPTTcToTs
021436 2002 Pus 45, M   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
021465 2002 Sputum 30, F   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
021523 2002 Sputum 65, F   dfrA12-orfF-aadA2   A ACiGLTToTs
021589 2002 Stool 25, M   dfrA12-orfF-aadA2   A ACiGLTToTs
021606 2002 Sputum 77, M   dfrA12-orfF-aadA2   A ACiGLTToTs
021648 2002 Blood 42, M   dfrA12-orfF-aadA2   A ACiGLTToTs
031819 2003 Sputum 75, M   dfrA12-orfF-aadA2   A ACiGLTToTs
031881 2003 Sputum 83, F   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
031997 2003 Pus 21, F   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
032070 2003 Sputum 80, M   dfrA12-orfF-aadA2   A ACiGLTToTs
032182 2003 Stool 26, F   dfrA12-orfF-aadA2   A ACiGLTToTs
032235 2003 Sputum 73, F     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
032296 2003 Blood 72, M   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
032300 2003 Sputum 78, F   aadA2   B AzCaCeCiGLPTTcToTs
032327 2003 Stool 22, M   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
032354 2003 Sputum 72, F   aadA2   B AzCaCeCiGLPTTcToTs
032372 2003 Blood 76, M   aadA2   B AzCaCeCiGLPTTcToTs
032406 2003 Stool 70, F   aadA2   B AzCaCeCiGLPTTcToTs
032422 2003 Sputum 72, M     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
032425 2003 Blood 72, F   aadA2   C ACeGPToTs
032432 2003 Sputum 47, M   dfrA12-orfF-aadA2   A ACiGLTToTs
042498 2004 Blood 85, M   aadA2   C ACeGPToTs
042511 2004 Sputum 67, F     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
042587 2004 Blood 24, M   aadA2   C ACeGPToTs
042597 2004 Sputum 65, M     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
042600 2004 Stool 74, F     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
042679 2004 Blood 71, M   aadA2   B AzCaCeCiGLPTTcToTs
042691 2004 Pus 36, M   aadA2   B AzCaCeCiGLPTTcToTs
042721 2004 Sputum 83, F   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
042728 2004 Sputum 48, M   aadA2   B AzCaCeCiGLPTTcToTs
042763 2004 Stool 83, F     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
042781 2004 Sputum 61, M   dfrA12-orfF-aadA2;
aadA2
  B AzCaCeCiGLPTTcToTs
042830 2004 Sputum 75, M   aacA4-catB3-dfrA1
(noncoding)
  F GPTTcTo
042869 2004 Stool 66, F     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
042872 2004 Sputum 53, M   sul3   G AAzCaCeCiGLPTTcToTs
042879 2004 Blood 71, F   dfrA12-orfF-aadA2;
dfrA17-aadA5
  B AzCaCeCiGLPTTcToTs
042890 2004 Sputum 48, M   aadA2   B AzCaCeCiGLPTTcToTs
042904 2004 Pus 28, F     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
042921 2004 Sputum 76, M   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
042963 2004 Blood 86, F   dfrA12-orfF-aadA2   B AzCaCeCiGLPTTcToTs
042975 2004 Stool 63, M     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
043001 2004 Sputum 71, F   aadA2   B AzCaCeCiGLPTTcToTs
051327 2005 Sputum 49, M     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
053203 2005 Blood 62, F   blaVIM-4–pse1   H AAzCaCeCiGLPTTcToTs
053375 2005 Sputum 33, F   sul3   G AAzCaCeCiGLPTTcToTs
053505 2005 Stool 46, M     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
054239 2005 Sputum 56, F     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
054297 2005 Blood 38, F     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
054313 2005 Sputum 55, M     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
054348 2005 Blood 44, F   sul3  dfrA1-sat1-aadA1 G AAzCaCeCiGLPTTcToTs
054372 2005 Sputum 43, F     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
054393 2005 Blood 57, F     dfrA1-sat1-aadA1 D AAzCaCeCiGLPTTcToTs
054429 2005 Sputum 49, M     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
054466 2005 Blood 60, F   blaVIM-4–pse1  dfrA1-sat1-aadA1 H AAzCaCeCiGLPTTcToTs
054498 2005 Sputum 51, M     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
054574 2005 Blood 29, F     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
054578 2005 Sputum 69, F   sul3  dfrA1-sat1-aadA1 G AAzCaCeCiGLPTTcToTs
055180 2005 Sputum 66, F     dfrA1-sat1-aadA1 E AAzCiGLPTTcToTs
a M, male; F, female.
b , present; , absent.
c A, amikacin; Az, aztreonam; Ca, ceftazidime; Ce, ceftriaxone; Ci, ciprofloxacin; G, gentamicin; L, levofloxacin; P, piperacillin; T, tetracycline; Tc, ticarcillin-
clavulanic acid; To, tobramycin; Ts, trimethoprim-sulfamethoxazole.
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